Stocks
60 Degrees Pharmaceuticals, Inc.SXTP
NASDAQHealthcareBiotechnology$0.87
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing prescription drug products for infectious diseases and other indications. Its lead candidate, a therapy for malaria, has received FDA approval, and the company is pursuing additional applications. Investors track SXTP for its regulatory progress and potential in the infectious disease market.
52W Range: $0.81-$8.62
Congressional Interest in 60 Degrees Pharmaceuticals, Inc. (SXTP)
No congressional trades have been disclosed for 60 Degrees Pharmaceuticals, Inc. (SXTP) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading SXTP?
No congressional trades found for this stock.